Investigation of monoclonal gammopathy of undetermined significance: A single-centre study

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The main characteristic of monoclonal gammopathies (MG) is the presence of an increased amount of both electrophoretically and immunologically homogeneous immunoglobulins (M component). According to the WHO classification, monoclonal gammopathies are classified among the non-Hodgkin's lymphomas as 'plasma cell dyscrasias'. The unknown behaviour state, so-called MGUS (monoclonal gammopathy of undetermined significance), is distinguished from the malignant diseases. We investigated the frequency and features of MG and MGUS by reviewing the serum immunochemistry protein analyses between 1998 and 2004. Among 18 642 analyses, MG was found in 1983 cases (10.39%) derived from one or more samples of 416 patients. Case histories of 340 patients were analysed. A malignant lymphoproliferative disease was proved in 171 cases, while in 169 cases the behaviour of the gammopathy was unknown. In 65 cases, the disease was possibly not related to MG. Mean follow-up time of the 65 patients with MGUS was 42 (9-81) months. During the follow-up period seven patients progressed into a malignant lymphoproliferative disorder - mean probability of the malignant transformation was 3.07%/year and it occurred more frequently in the presence of immunoglobulin A isotype. There was no correlation between the progression of the disease and other laboratory findings. Besides the analyses of MG-related diseases, we focus on the malignant transformation of MGUS and on the importance of regular clinical and laboratory control examinations.

Original languageEnglish
Pages (from-to)164-169
Number of pages6
JournalClinical and Laboratory Haematology
Volume28
Issue number3
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Monoclonal Gammopathy of Undetermined Significance
Paraproteinemias
Myeloma Proteins
Immunochemistry
Immunoglobulin A
Immunoglobulin M
Blood Proteins
Lymphoproliferative Disorders
Immunoglobulin Isotypes
Non-Hodgkin's Lymphoma
Plasmas
Disease Progression

Keywords

  • Gammopathy
  • Immunglobulin
  • Monoclonal
  • Plasma cell

ASJC Scopus subject areas

  • Hematology

Cite this

@article{8f70ff872f0c40cb82db8ad1c021583d,
title = "Investigation of monoclonal gammopathy of undetermined significance: A single-centre study",
abstract = "The main characteristic of monoclonal gammopathies (MG) is the presence of an increased amount of both electrophoretically and immunologically homogeneous immunoglobulins (M component). According to the WHO classification, monoclonal gammopathies are classified among the non-Hodgkin's lymphomas as 'plasma cell dyscrasias'. The unknown behaviour state, so-called MGUS (monoclonal gammopathy of undetermined significance), is distinguished from the malignant diseases. We investigated the frequency and features of MG and MGUS by reviewing the serum immunochemistry protein analyses between 1998 and 2004. Among 18 642 analyses, MG was found in 1983 cases (10.39{\%}) derived from one or more samples of 416 patients. Case histories of 340 patients were analysed. A malignant lymphoproliferative disease was proved in 171 cases, while in 169 cases the behaviour of the gammopathy was unknown. In 65 cases, the disease was possibly not related to MG. Mean follow-up time of the 65 patients with MGUS was 42 (9-81) months. During the follow-up period seven patients progressed into a malignant lymphoproliferative disorder - mean probability of the malignant transformation was 3.07{\%}/year and it occurred more frequently in the presence of immunoglobulin A isotype. There was no correlation between the progression of the disease and other laboratory findings. Besides the analyses of MG-related diseases, we focus on the malignant transformation of MGUS and on the importance of regular clinical and laboratory control examinations.",
keywords = "Gammopathy, Immunglobulin, Monoclonal, Plasma cell",
author = "Z. Simon and S. Sipka and L. Gergely and I. Cs{\'i}pő and A. Ill{\'e}s",
year = "2006",
month = "6",
doi = "10.1111/j.1365-2257.2006.00776.x",
language = "English",
volume = "28",
pages = "164--169",
journal = "International Journal of Laboratory Hematology",
issn = "1751-5521",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Investigation of monoclonal gammopathy of undetermined significance

T2 - A single-centre study

AU - Simon, Z.

AU - Sipka, S.

AU - Gergely, L.

AU - Csípő, I.

AU - Illés, A.

PY - 2006/6

Y1 - 2006/6

N2 - The main characteristic of monoclonal gammopathies (MG) is the presence of an increased amount of both electrophoretically and immunologically homogeneous immunoglobulins (M component). According to the WHO classification, monoclonal gammopathies are classified among the non-Hodgkin's lymphomas as 'plasma cell dyscrasias'. The unknown behaviour state, so-called MGUS (monoclonal gammopathy of undetermined significance), is distinguished from the malignant diseases. We investigated the frequency and features of MG and MGUS by reviewing the serum immunochemistry protein analyses between 1998 and 2004. Among 18 642 analyses, MG was found in 1983 cases (10.39%) derived from one or more samples of 416 patients. Case histories of 340 patients were analysed. A malignant lymphoproliferative disease was proved in 171 cases, while in 169 cases the behaviour of the gammopathy was unknown. In 65 cases, the disease was possibly not related to MG. Mean follow-up time of the 65 patients with MGUS was 42 (9-81) months. During the follow-up period seven patients progressed into a malignant lymphoproliferative disorder - mean probability of the malignant transformation was 3.07%/year and it occurred more frequently in the presence of immunoglobulin A isotype. There was no correlation between the progression of the disease and other laboratory findings. Besides the analyses of MG-related diseases, we focus on the malignant transformation of MGUS and on the importance of regular clinical and laboratory control examinations.

AB - The main characteristic of monoclonal gammopathies (MG) is the presence of an increased amount of both electrophoretically and immunologically homogeneous immunoglobulins (M component). According to the WHO classification, monoclonal gammopathies are classified among the non-Hodgkin's lymphomas as 'plasma cell dyscrasias'. The unknown behaviour state, so-called MGUS (monoclonal gammopathy of undetermined significance), is distinguished from the malignant diseases. We investigated the frequency and features of MG and MGUS by reviewing the serum immunochemistry protein analyses between 1998 and 2004. Among 18 642 analyses, MG was found in 1983 cases (10.39%) derived from one or more samples of 416 patients. Case histories of 340 patients were analysed. A malignant lymphoproliferative disease was proved in 171 cases, while in 169 cases the behaviour of the gammopathy was unknown. In 65 cases, the disease was possibly not related to MG. Mean follow-up time of the 65 patients with MGUS was 42 (9-81) months. During the follow-up period seven patients progressed into a malignant lymphoproliferative disorder - mean probability of the malignant transformation was 3.07%/year and it occurred more frequently in the presence of immunoglobulin A isotype. There was no correlation between the progression of the disease and other laboratory findings. Besides the analyses of MG-related diseases, we focus on the malignant transformation of MGUS and on the importance of regular clinical and laboratory control examinations.

KW - Gammopathy

KW - Immunglobulin

KW - Monoclonal

KW - Plasma cell

UR - http://www.scopus.com/inward/record.url?scp=33646726318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646726318&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2257.2006.00776.x

DO - 10.1111/j.1365-2257.2006.00776.x

M3 - Article

C2 - 16706932

AN - SCOPUS:33646726318

VL - 28

SP - 164

EP - 169

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

SN - 1751-5521

IS - 3

ER -